For the Inventor, By the Inventor

Enter assignee name

Sanofi-synthelabo

USPTO Granted Patents = 152

CIPO Patents = 7

Trademarks = 21

Forward Citations = 2,447

Loading Chart...

Loading Chart...

342 inventors (with patents filed for the assignee):

Alistair Lochead (11 out of 75 patents)

Bertrand Castro (11 out of 14 patents)

Samir Jegham (10 out of 39 patents)

4. Xavier Emonds-Alt (9 out of 46 patents)

5. Claudine Serradeil-Le Gal (8 out of 21 patents)

6. Vincenzo Proietto (8 out of 47 patents)

7. Patrick Gueule (7 out of 32 patents)

8. Marc Brunel (7 out of 9 patents)

9. Didier Van Broeck (7 out of 40 patents)

10. Daniel Bichon (6 out of 41 patents)

11. Jean-Robert Dormoy (6 out of 13 patents)

12. Frédéric Galli (6 out of 6 patents)

13. Pierre Casellas (5 out of 48 patents)

14. Yvette Muneaux (5 out of 15 patents)

15. Claude Muneaux (5 out of 10 patents)

Core Competencies:

Pharmaceutical Microspheres

Benzimidazole Derivatives

Aminoalkoxybenzoyl Compounds

Antipsychotic Cyclic Compounds

Polysaccharides Antithrombotic Activity

GSK3 Inhibitors

Tetrahydropyridine Derivatives

Cannabinoid Receptor Antagonists

Indolin-2-One Derivatives

Phenoxypropanolamines

Disposable Injection Devices

Human NK3 Receptor Antagonists

152 patents: Sort by Forward Citations

1. 8535721 - Pharmaceutical microspheres containing valproic acid for oral administration (2013-09-17),

2. 7427615 - 3-substituted-4-pyrimidone derivatives (2008-09-23),

3. 6979683 - Benzimidazole derivatives, preparation and therapeutic use thereof (2005-12-27),

4. 6949583 - Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same (2005-09-27),

5. 6918889 - Disposable injection device (2005-07-19),

6. 6916929 - Method for preparing 4-methylamino-4-phenylpiperidine (2005-07-12),

7. 6908927 - Pyridopyranoazepine derivatives, their preparation and their therapeutic application (2005-06-21),

8. 6908914 - Antipsychotic cyclic N-aralkylamines (2005-06-21),

9. D505320 - Packaging for a drug blister-pack for clinical trial (2005-05-24),

10. 6894186 - Hydroxyacetic ester derivatives, preparation method and use as synthesis intermediates (2005-05-17),

11. 6867220 - Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them (2005-03-15),

12. 6864277 - 1,3-dihydro-2H-indol-2-one derivatives, method for preparing same and pharmaceutical compositions containing them (2005-03-08),

13. 6861072 - Pharmaceutical composition with gastric residence and controlled release (2005-03-01),

14. 6858629 - Heteroaryloxy propanolamines, preparation method and pharmaceutical compositions containing same (2005-02-22),

15. 6852736 - Phenoxypropanolamines, preparation and therapeutic use thereof (2005-02-08),

Sanofi is a multinational pharmaceutical company that specializes in the research, development, production, and marketing of pharmaceutical drugs. With over 100,000 employees worldwide, Sanofi aims to improve people's health and well-being by delivering innovative therapeutic solutions. They focus on various therapeutic areas, including diabetes, cardiovascular diseases, rare diseases, vaccines, and more. Visit their website for more information.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

152 Patents

#45 in Paris

#179 in France

#5,234 in the World

Sanofi-synthelabo

Forward Citations = 2,447

342 inventors:

Alistair Lochead (11 out of 75 patents)

Bertrand Castro (11 out of 14 patents)

Samir Jegham (10 out of 39 patents)

4. Xavier Emonds-Alt (9 out of 46 patents)

5. Claudine Serradeil-Le Gal (8 out of 21 patents)

Please report any incorrect information to support@idiyas.com

Loading…